What's New in Research Funding

Page last updated February 15, 2018.

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates:

Join in U of T’s advocacy efforts as we urge the federal government to implement all of the Fundamental Science Review Report’s recommendations. Get involved today and #supportthereport by phoning or writing your MP, sending a postcard to Ottawa, or making your support for research known on social media.
 

February 15, 2018
 

  • CIHR Gender-Net Plus: Call for ProposalsCIHR has announced that funds are available to support Canadian researchers interested in investigating sex and gender in health through transnational collaborations. Through the leadership of the CIHR Personalized Health Initiative, the CIHR Institute of Gender and Health is a member of GENDER-NET Plus - an international consortium of 16 research funders in 13 countries. These 16 partners have joined forces to launch a co-funded Call for Proposals, to support research that aims to address urgent societal challenges through a sex and gender lens. The recorded applicant webinar, linkage tool, partners list and timelines for this funding opportunity can now be accessed on the CIHR Gender-Net Plus website.
    Pre-proposal deadline to Gender-Net is March 1, 2018, 5 p.m. CET, and the full application deadline to CIHR is July 16, 2018.
     
  • Team Grants in Nutrition and the Epigenome. The aim of this call is to support transnational, collaborative research projects that gain a better understanding of the diet-epigenome relationships and their effect on human health. This will allow the development and scientific substantiation of intervention strategies for treating nutrition-related diseases and sustaining good health throughout the life course. The total CIHR amount available for the Canadian component of successful projects is $900,000 CAD, enough to fund approximately two grants. The maximum amount per Canadian component of the grant is $150,000/year for up to three years. More details are available at Joint Programme Initiative Healthy Diet for a Healthy Life (JPI HDHL).  The application deadline is April 12, 2018.
     
  • ERA-NET NEURON: 2018 Mental Disorders. The aim of this call is to facilitate multinational, collaborative research projects that will address important questions related to mental health and mental disorders across the entire lifespan. In addition to the application submission (in English) to the NEURON Joint Call Secretariat, Canadian consortium members applying for CIHR funding must complete an abbreviated CIHR application (in either of Canada's official languages) and submit it using ResearchNet. Deadline for pre-proposal submissions: March 8, 2018.
     
  • Azrieli Foundation and Brain Canada launch: Early-Career Capacity Building Grants. This program is targeting Early-Career Researchers, within 3 years of their first research or university appointment, and will provide $100,000 over 2 years that will enable innovative and original research with the high potential for a meaningful impact. The general purpose of the Early-Career Capacity Building Grant program is to accelerate novel and transformative research that will fundamentally change our understanding of nervous system function and dysfunction and their impact on health. The goal is to reduce the social and economic burden of neurological and mental health problems by prevention, early diagnosis, and treatment. Deadline for full applications: April 17, 2018 at 4pm ET.
     
  • NIH Common Fund for Somatic Cell Genome Editing. This funding opportunity aims to support the establishment of a dissemination and coordination centre for the NIH somatic cell genome editing consortium.  The consortium will create validated techniques on genome editing tools, delivery systems, animal models and biological assays. Awardees participating in the consortium will develop consensus policies and procedures for activities such as data sharing. Read moreApplications will be open on March 3, 2018 with an end date of April 3, 2018.
     
  • LGS (Lennox-Gastaut Syndrome) Foundation. The LGS Foundation's seed grant program awards research grants to young investigators, physician residents, and clinicians who are interested in studying Lennox-Gastaut Syndrome (LGS), a rare and often debilitating form of childhood-onset epilepsy. These seed grants are intended to help researchers explore novel ideas and answer questions related to the clinical aspects, therapies and/or genetic causes of LGS. Seed Grants and Post-Doctoral Fellowships are available. The seed grant program awards one-year research grants up to $30,000 USD and two-year grants up to $50,000 USD. Deadline for letters of intent: March 1, 2018.
     
  • Pfizer Inc.: Understanding the Importance of Calcium and Vitamin D Supplementation for Aging Men. The intent to support projects that focus on increasing the awareness about elements essential to healthy ageing in men and the components that need to be managed to maintain. Primary focus should be on bone health and Calcium and Vitamin D supplementation. The target learner audiences include healthcare professionals with a focus on prevention and treatment of male osteoporosis, and General practitioners. The total available budget is $200,000 USD. Deadline for applications: March 19, 2018.
     
  • Organization for Autism Research (OAR): Applied Research Competition. OAR seeks to fund studies that expand the body of knowledge related to autism intervention and treatment, produce practical and clearly objective results, have the potential to impact public policy, and provide outcomes that offer to enhance quality of life for persons with autism and their families. While applicants are always free to submit on any relevant area of research or intervention, this year, OAR is placing an emphasis on research that addresses the following targeted areas: healthcare transition, generalization of technology-based intervention, community-based intervention, residential services and supports, literacy, and sexuality education. OAR will consider awarding up to 8 grant awards for $30,000 USD. Deadline for preliminary proposals: March 26, 2018.
     
  • International Essential Tremor Foundation (IETF): Grant Program. The aim of this request is to stimulate inquiry into this poorly understood clinical disorder and to provide support to projects that are innovative and give promise of receiving more substantial support from NIH, K Award or R01 and/or other sources if sufficient preliminary information can be obtained from projects supported by the IETF. Upper amount $25,000 USD. Deadline for proposals: February 28, 2018.
     
  • National Organization for Rare Diseases: Current Research Funding Opportunities. Deadlines are ongoing. Questions should be directed to research@rarediseases.org
    • Cat Eye Syndrome – One grant of up to $30,000 for scientific and/or clinical research studies related to Cat Eye Syndrome
    • Malonic Aciduria – One grant of up to $50,000 for scientific and/or clinical research studies related to Malonic Aciduria
    • Post-Orgasmic Illness Syndrome – One grant of up to $31,000 for scientific and/or clinical research studies related to Post-Orgasmic Illness Syndrome (POIS)

February 7, 2018
 

  • The College of Reviewers (College) is pleased to announce the launch of its Membership Progression Program. The College is developing capacity through its Membership Progression Program to allow those individuals who do not currently meet all of the academic membership selection criteria to become a part of the College. The program provides an opportunity for new or less experienced reviewers to build the reviewing skills and experiences necessary to be eligible to obtain full College Member status. Those invited to join the College as an Associate Member are provided with the training and support to develop their reviewing skills, as well as the direct hands-on peer review experience to reinforce how to conduct quality reviews. Recruitment begins in February 2018! Read more.
     
  • Gordon F. Cheesbrough Research Chair in Family and Community Medicine, North York General Hospital and Director, UTOPIAN, University of Toronto Department of Family and Community Medicine. North York General Hospital (NYGH) and the University of Toronto invite applications for the joint position of Gordon F. Cheesbrough Research Chair in Family and Community Medicine and Director, UTOPIAN – the University of Toronto Practice-Based Research Network. The Gordon F. Cheesbrough Research Chair in Family and Community Medicine was established at NYGH to support an outstanding academic individual with a demonstrated track record in research excellence. This individual will also be the Director of UTOPIAN, which is a practice-based research network of 14 academic family medicine teaching units affiliated with the University of Toronto Department of Family and Community Medicine (DFCM). Review of applications will continue until March 31, 2018. Read the full posting.
     
  • Prostate Cancer Foundation: 2018 PCF Challenge Awards for Metastatic, Lethal Prostate Cancer (A Request for Team Science Applications). These awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired. They especially seek applications conducting research in VA hospitals where research directly affects veterans with advanced prostate cancer. The Movember Foundation will fund approximately three (3) Movember Foundation-PCF Challenge Awards from U.S.-based teams with money it has raised in the U.S. Other funding sources will support additional PCF Challenge Awards at institutions from within or outside the U.S. View the RFA for complete details. Deadline for applications: April 23, 2018 at 3:00pm EDT.
     
  • Cancer Research Society: LAUNCH - Scholarships for the Next Generation of Scientists: 2018 Competition. This initiative is aimed at supporting future generations of Canadian researchers. Questions should be directed to Lucille Beaudet or Irina Navarrete at grants@src-crs.ca or, toll free, 1 888-766-2262. Deadline for applications: April 27, 2018 EST. Visit their website for additional information.  The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal.
    • Part 1: Postdoctoral Salary Award - 1 year - $40,000
    • Part 2: Operating Grant - 2years - $120,000 ($60,000 per year)
       
  • Networks of Centres of Excellence (NCE): AGE-WELL SIP Accelerator Program. AGE-WELL is dedicated to the creation of technologies and services that benefit older adults and caregivers. Their aim is to help older Canadians maintain their independence, health and quality of life through technologies and services that increase their safety and security, support their independent living, and enhance their social participation. AGE-WELL’s SIP Accelerator program supports innovative post-discovery projects focused on the commercialization and/or knowledge mobilization of solutions (e.g. technologies, services or policies) aligned with AGE-WELL’s mission and vision . The program provides financial support (up to $40,000 over 1 year, may be renewed for an additional year); training opportunities; and strategic mentorship. UofT internal deadline: February 24, 2018; Sponsor deadline: March 2, 2018.
     
  • ERA PerMed: Research Projects on Personalized Medicine – Smart Combination of Pre-clinical and Clinical Research with Data and ICT Solutions. ERA PerMed is an ERA-Net Cofund, supported by 31 partners of 22 countries and cofunded by the European Commission. The aim of this Funding Opportunity is to fund projects showing clinical feasibility of Personalized Medicine in complex/multifactorial diseases as well as other diseases (as monogenic, rare diseases and cancer). Applicants are expected to combine pre-clinical and/or clinical research with bio-informatics components to enable data quality on one side and the potential applicability for health care providers on the other side. Proposals must be interdisciplinary and clearly demonstrate the potential impact in PM as well as the added value of transnational collaboration: sharing of resources (registries, diagnosis, biobanks, models, databases, diagnostic and bio-informatics tools, etc.), platforms/infrastructures, interoperability of data harmonization strategies and sharing of specific know-how. Read more.
    Information Webinar: February 12, 2018, 1pm-2pm ET. Register here.
    Deadline for pre-proposals: April 10, 2018.
     
  • Canada-EU Commission Flagship Collaboration for Human data storage, integration and sharing. CIHR and FRQS are pleased to announce that funding is available to support Canadian researchers interested in collaborating in the domain of repositories storing and sharing human-omics data that will create a framework for long-term cooperation through transnational collaborations with European researchers. The goal of this program aims to enhance and standardize data deposition, curation and exchange procedures thus ensuring better data reuse and increased benefit to the scientific communities worldwide. This is a unique collaboration, and CIHR’s first European Commission Research and Innovation Action (RIA), which will require each project to involve at least one Canadian investigator and three European investigators fundable by the European Commission. The call for proposals was launched on October 27, 2017.  Read more
    Information Webinar: February 12, 2018, 11am-12pm ET. Register here.
     
  • Alzheimer's Drug Discovery Foundation (ADDF): Preclinical Drug Discovery. The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising preclinical drug discovery and biomarker development programs relevant to Alzheimer's disease, other dementias and cognitive aging. Amount: $150,000-$600,000 USD based on stage and scope of research. Deadline for Letters of Intent: April 13, 2018.
     
  • National Marfan Foundation: Faculty Grant Program. The faculty grant program supports two-year grants for basic or clinical research for all disciplines in Marfan syndrome, Ehlers Danlos syndrome, Loeys Dietz syndrome and other related disorders. Work can be performed in the U.S. or internationally. Awards are $50,000 USD per year for two years. Deadline for proposals: April 20, 2018.
     
  • AACR-Johnson & Johnson Lung Cancer Innovation Science Grants. Proposals should focus on understanding the behaviors that lead to chronic exposures to respiratory carcinogens and how these behaviors can be modified; how chronic exposures produce cellular/genomic damage and how these can be ameliorated; deciphering the types of inflammation that underlie the carcinogenic process; understanding the alterations in innate and adaptive immunity that create an immune-permissive microenvironment; and changes in the pulmonary microbiome that may contribute to carcinogenesis. Proposals that characterize premalignant lesions or that substantially improve the detection of lung cancer at more curable stages will also be prioritized. This project must be implemented by a multi-institutional team, composed of Principal Investigators from at least two, but no more than three, different institutions. The Grant will provide $1.5 million USD in funding for direct and indirect expenses related to each research project over a three year timeframe. Deadline for applications: March 2, 2018.
  • International OCD Foundation (IOCDF): Young Investigator/Fellow Award and Breakthrough Award. The IOCDF awards grants to investigators whose research focuses on the nature, causes, and treatment of OCD and related disorders. Post-doctoral fellows are encouraged to apply; however, a letter from their mentor is required at the time of application. Senior investigators may also ask for grant funding for projects that would provide pilot data for future larger scale federal grant applications. Up to $50,000 USD per award for Young Investigator/Fellow Award and 2 awards of $500,000 USD over 3 years for the Breakthrough Award. Deadline for Proposals: February 28, 2018.

January 25, 2018
 

  • NEW - Ontario Ministry of Health and Long-Term Care (MOHLTC): Targeted Call for Patient-Oriented Research in Mental Health and Addictions.  The MOHLTC is excited to launch a new funding competition through the Ministry’s Health System Research Fund (HSRF). The Targeted Call for Patient-Oriented Research in Mental Health and Addictions will support 24-month grants of up to $250,000 per year for research with the potential to improve Ontario’s mental health and addictions system. Grants funded through this competition should demonstrate strong partnership with people with lived experience throughout the entirety of research project: from project conception and writing of the grant application through governance, implementation, data analysis and interpretation, and knowledge translation and exchange. Grant applications will be reviewed not only by scientific peer-reviewers, but also by people with lived experience and sector experts. Contact E-mail : ResearchUnit@ontario.ca. Deadline for mandatory Notice of Intent: February 20, 2018: Full application due: March 14, 2018.
     
  • Genome Canada:  Genomic Applications Partnership Program (GAPP) - 2 new rounds are open. The GAPP funds public-private research collaborations focused on developing genomics-derived technologies that address opportunities and challenges identified by industry, government, not-for-profits or other “Receptors” of genomics knowledge and tools. Key Program Highlights: Project budgets: $300K-$6M (total); Co-funding: 1/3 Genome Canada (max), 1/3 Receptor (min), 1/3 other; Award duration: 1 to 3 years; Stage: Downstream R&D/validation/pilot.
    Please contact Shobha Ramsubir, Senior Manager, Business Development and Research, to initiate your application and to obtain the application form (applicants are encouraged to do this well ahead of the due dates).
    Details and timelines can be found here.
    Examples of previously funded GAPP projects

     
  • LAUNCH: SickKids-CIHR-IHDCYH New Investigator Grants in Child and Youth Health. New Investigator Grants provide important early career development support to child health researchers. The competition is open to early career investigators from any CIHR eligible institution, who may apply for up to 3 years' support for research in biomedical, clinical, health systems and services, population and public health sectors. The maximum amount for a single grant is $300,000 ($100,000 per year for up to 3 years). Deadline for applications: April 20, 2018. 
     
  • CIHR Pre-announcement: CIHR Early Career Investigators in Maternal, Reproductive, Child and Youth Health (2018). The program funds research that has the potential to have a significant impact on maternal, reproductive, child and youth health outcomes. Ultimately, the program aims to strengthen Canada’s capacity and knowledge to respond to challenges and needs by providing important early career development support to researchers in these fields. The total amount available from CIHR for the 2018 funding opportunity is $1,260,000, enough to fund up to 12 grants.  III will fund 1 grant for a project relevant to its mandate. Registration: April 2018; Application: May 2018.
     
  • JDRF Canadian Clinical Trials Network (JDRF CCTN) and Eli Lily Canada Inc.: Postdoctoral Fellowships in Clinical Translation in T1D Program. Two Fellowships will be offered at $60,000 each for a term of one-year.  Please see the RFA for background, eligibility criteria, and application details. Application deadline: March 27, 2018.
     
  • Kidney Foundation of Canada (KFOC) and Partners: Alport Syndrome Research Funding. The objective of this research funding program is to advance the knowledge of, develop effective treatment protocols for, and discover a cure for Alport Syndrome Foundation. Funding will be provided for basic science or clinical research on Alport Syndrome. These funds may be used as seed funding for the testing of initial hypotheses and the collection of preliminary data leading to successful long-term funding by the National Institutes of Health (NIH), the Canadian Institutes of Health Research (CIHR), or other major funding institutions around the world. It is anticipated that two research projects will be selected for funding, totaling $100,000 USD each, over a one- to two-year timeframe. Deadline for applications: February 9, 2018.
  • Canadian Liver Foundation: Operating Grants. Deadline for applications: March 31, 2018.
    • Two grants may be awarded to researchers in Canada whose research projects are related to hepatobiliary research
    • One grant may be awarded to a researcher in Ontario whose research project is related to liver cancer
    • One grant may be awarded to a researcher in Ontario whose research project is related to pediatric liver disease
       
  • Association for Frontotemporal Degeneration (AFTD): Pilot Grants - Nonpharmacological Therapies and Tools for FTD Pilot Grant (NEW). AFTD is pleased to announce a Request for Proposals for a new Pilot Grant focused on nonpharmacological interventions and tools with the potential to have a positive impact on the quality of life for persons diagnosed and their families. The grant is open to US and international investigators. New or early-career researchers within 10 years of their first faculty appointment or equivalent in a for-profit organization are especially encouraged to apply. Upper amount: up to $60,000 USD for one year. Deadline for applications: March 19, 2018.
  • CHEST Foundation Grants. Applicant Qualifications:
    - CHEST membership at time of application. 
    - Applicants must be licensed physicians. Physicians-in-training (residents or fellows), other health-care professionals, or clinical researchers with relevant experience will also be accepted. Although applicants may be at later career stages, special consideration will be given to young investigators and applicants in early stages of their careers. 
    - Teams are encouraged to apply but must have a representative to serve as the Principal Investigator who will apply as an individual and will receive recognition if awarded. 
    Please visit their website to see the full list of the 2018 Requests for Proposals for grant funding.  Deadline for applications: April 9, 2018.
     
  • Alliance for Cancer Gene Therapy (ACGT): 2018 Investigator Award in Cell and Gene Therapy for Cancer. ACGT funds research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. Preference will be given to those working in solid tumors, orphan tumors or pediatric tumors, and to research not previously funded, thus highly innovative proposals. Candidates  must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty. Award amount: Up to $500,000 over 2-3 years. View the RFA for further details and how to apply. Abstract Deadline: March 13, 2018 at 11 am EST; Deadline for invited complete applications: May 15, 2018 at 11 am EST.

January 17, 2017
 

  • Medicine by Design Postdoctoral Fellowship Award 2018. Medicine by Design   is accepting applications for its 2018 Postdoctoral Fellowship Award. This award will provide funding to high calibre postdoctoral candidates at University of Toronto and its affiliated hospitals with outstanding potential to become independent researchers in the regenerative medicine field. Each award is up to a maximum of $50,000/year for three years towards salary support, from April 1st, 2018 to March 31st, 2021. Funds cannot be used for travel or other expenditures. Please download the guidelines and application form for eligibility critieria and further details. Questions should be directed to awards.mbd@utoronto.ca. Deadline for submissions: February 5, 2018 at 5pm EST.
     
  • CIHR Observer Program - Opportunity for Early Career Investigators: Call for expressions of interest. CIHR is pleased to continue to offer an Observer program for early career investigators (ECIs) to participate as an observer in the peer review process of the Project Grant: Spring 2018 competition. Selected ECIs will be invited to observe committee meetings taking place in Ottawa as part of the review process for the Project Grant competition. There will be one ECI per committee.  As observers, the ECIs will not participate in review discussions. The face-to-face meetings will be held in Ottawa in May and June 2018. Exact dates will be confirmed with each selected ECI once they are assigned to a committee. CIHR will cover the travel costs for the ECI to attend the committee meeting. Deadline for expressions of interest: February 21, 2018.
     
  • Holland Bloorview Kids Rehabilitation Hospital: 2018 Pursuit Award Competition. The 2018 Pursuit Award competition, recognizing outstanding achievements in childhood disability research by PhD students and recent alumni from across the globe. Eligibility: Current PhD students (less than six months away from defence), postdoctoral trainees, and recent graduates (within one year of receiving their PhD) with a focus in any applied or clinical research specifically linked to childhood disability. Criteria: Finalists are chosen based on significance of research results, methodological rigour, empirical content, and impact on childhood disability care. Awards: Up to three cash prizes will be awarded. The top three candidates will be invited to present their research and compete during the annual Pursuit Award Ceremony at Holland Bloorview on May 15, 2018. Finalists may also be eligible for a prestigious post-doctoral fellowship at the Bloorview Research Institute. All travel and accommodation costs will be covered. Deadline for applications: Friday, February 2, 2018 at 5pm.
     
  • Mitacs Elevate: Winter 2018 (PostDoc fellowships, all disciplines) - DEADLINE UPDATED. Mitacs Elevate is a postdoctoral fellowship with a customized research management training component. Elevate fellows progress through the program in a cohort, giving them cross-disciplinary networking and peer-learning opportunities they might not have otherwise in their careers. Over the two-year fellowship, Elevate fellows divide their time between their partner organization project and university-based research with their faculty supervisor. UPDATED - UofT internal deadline: February 19, 2018; Sponsor deadline: February 21, 2018.
     
  • Call for International Doctoral Cluster (IDC) Applications. What is an IDC? International Doctoral Cluster is a research and doctoral education arrangement in a well-defined area/issue of research that brings together a critical mass of complementary talent (PIs, PDFs and graduate students) at U of T and partner institutions (academic/corporate/NGO etc.) in the form of an alliance that is more than the sum of its parts. The goal is to support cross-disciplinary and border collaborations to catalyze new ideas and transformational innovations. Funding model: Office of the Vice-President International (OVPI) and the School of Graduate Studies (SGS) will seed fund the associated mobility costs for U of T students, PDFs, and faculty.  OVPI and SGS will fund up to 1/3rdof the budget, generally, capped at 33,000 CAD/Year; PIs should mobilize the rest from within and beyond the University (e.g. division, Tri-Agency, industry,  philanthropy etc.). Further details here. Interested U of T faculty should collaborate with international partners to develop a 2 – 3 page proposal and submit it to OVPI. Deadline for proposals: February 1, 2018.
     
  • RBC Prize for Innovation and Entrepreneurship. Do you have a great idea for a company or are you already working in an innovative startup? The RBC Prize for Innovation and Entrepreneurship is an annual business pitch competition to recognize, reward and accelerate U of T’s innovative technologies and startups. Part of the Entrepreneurship@UofT Week Startup Showcase, the competition will take place Thursday, March 1st at MaRS. Selected individuals or teams will compete by showcasing their business idea via a 5-minute pitch to a panel of judges for the following prizes: Early Stage Prizes: 1st Prize $10,000; 2nd Prize $5,000. Later Stage Prizes: 1st Prize $25,000; 2nd Prize $10,000. Further information here. Deadline to apply: January 26, 2018.
     
  • EU Horizon 20/20, and European Research Funding Information Session. The University is pleased to invite those interested in learning more about multidisciplinary funding opportunities from the EU Horizon 20/20 program to an information session to be held at the time and location noted below.  The session will be led by Mr. Luigi de Masellis, who is the Advisor for Economic and Commercial Affairs with the Delegation of the European Union to Canada. While funding to Canadian faculty participating on Horizon 20/20 collaborations is not guaranteed, the information session will cover participation in these opportunities.  Horizon 20/20 has close to 80 billion Euros of funding available during its current mandate (2014 to 2020.)  In addition, there will be discussion about funding available for Canadian researchers for individual grants from the European Research Council, and the Marie Sklowdowska-Curie Actions. More details about the programs can be found here:  EU Horizon 20/20; European Research CouncilMarie Sklowdowska-Curie Actions.
    Date: January 26, 2018 from 10 am-12 noon
    Location: Governing Council Board Room, Simcoe Hall, Room 209 (St. George Campus
    Please RSVP to Julia Kulik, Office of the Vice-President, International Relations at julia.kulik@utoronto.ca
     
  • The Kidney Foundation of Canada: Allied Health Doctoral Fellowships and Scholarships 2018. The application forms  are now available on the Foundation's website. Please note the forms and guidelines have been revised. Deadline for applications: March 15, 2018.
    • Allied Health Doctoral Fellowships: The Foundation offers a limited number of fellowships designed to provide for full-time academic and research preparation at the doctoral level. The objective of this program is to promote and enhance the development of nephrology/organ donation allied health investigators in Canada. The award is for up to $31,000/year and is tenable in Canada or abroad (for programs outside Canada, the applicant must provide a statement indicating the intention to return to Canada).
    • Allied Health Scholarships: The purpose of the Allied Health Scholarship award is to assist the student with a demonstrated interest in nephrology/organ donation in pursuing education at the Masters level to promote and enhance the development of nephrology allied health investigators in Canada.
       
  • Huntington Society of Canada: Navigator Research Program 2018. This program supports basic scientific research of direct and immediate relevance to Huntington Disease in Canada with the aim of providing a platform for the recruitment of outstanding investigators to HD research, to facilitate research collaboration nationally and internationally, and to support research that is relevant to other neurodegenerative disorders. Deadline for Letters on Intent: February 15, 2018 at 3pm ET.
     
  • Prostate Cancer Foundation (PCF): Young Investigator Awards. The Prostate Cancer Foundation (www.pcf.org) champions investment in human capital to fast-forward solutions for prostate cancer with the ultimate goal of ending death and suffering from metastatic prostate cancer. We continue to focus significant efforts on developing gifted cohorts of young prostate cancer researchers and are pleased to announce a new round of funding for PCF Young Investigators. We especially seek young investigators with appointments in VA hospitals where research directly affects veterans with advanced prostate cancer. View the RFA for complete details. Deadline for submissions: March 19, 2018, at 3pm EDT.
     
  • Saving Lives at Birth: A Grand Challenge for Development (Grand Explorations (GCE): Saving Lives at Birth). The Sponsors are seeking groundbreaking prevention and treatment approaches for pregnant women and newborns in poor, hard-to-reach communities around the time of delivery. This is the period when the majority of maternal and newborn deaths occur and the population that has been the most difficult to reach. We seek innovative ideas that can leapfrog conventional approaches in three main domains: (1) technology; (2) service delivery; and (3) “demand side” innovation that empowers pregnant women and their families to practice healthy behaviors and be aware of and access health care during pregnancy, childbirth and the early postnatal period, especially the first two days after birth. Deadline for Expressions of Interest: February 28, 2018 at 2pm ET.
     
  • amfAR Impact Grants: Gaining Insights from the Clinic. The goal of this RFP is to generate practical, implementable information that will facilitate the design and interpretation of broadly generalizable HIV cure clinical research. Specific areas of interest: 1) Identify pre-ATI predictors of post-treatment control (PTC) or delay to rebound; 2) Diversify the HIV cure clinical study population. Please visit their website to view the available funding opportunities within this RFP. Registration deadline: April 6, 2018 at 12pm ET; Deadline for Letters of Intent: April 11, 2018 at 3pm ET.

     

January 9, 2018
 

  • CIHR Webinars on the Project Grant: Spring 2018 Application. CIHR is holding a series of webinars on the Project Grant: Spring 2018 application. These Question and Answer webinars are designed to complement the Project Grant: Spring 2018 Applicant Learning Module, which will be available on January 19th on the Learning for Applicants web page. Together, the module and webinars will give applicants an insightful understanding of the recent changes to the Project Grant competition and the application submission process. The Project Grant: Spring 2018 webinars will be held between January 26th and February 28th. Register for a webinar now.
    For more information, please contact the CIHR Contact Centre at: Support@cihr-irsc.gc.ca
     
  • CIHR Project Grant: Spring 2018 Priority AnnouncementsThe specific objective of the Project Grant: Spring 2018 Priority Announcements is to offer additional sources of funding for highly rated applications that are relevant to specific research areas. CIHR Research Priority Areas:
  • Michael Bahen Chair in Epilepsy Research at the University of Toronto. The Faculty of Medicine at the University of Toronto invites applications for the Michael Bahen Chair in Epilepsy Research. The Michael Bahen Chair in Epilepsy Research was established to support an outstanding academic individual with a demonstrated track record in research and clinical excellence within the field of epilepsy. This individual should have demonstrated success in epilepsy research and creative professional activity within epilepsy management with a particular focus on complex and/or inherited forms of epilepsy. Read more...
     
  • Alberta Innovates/Alberta Prion Research Institute: New Collaborations Program (New)The New Collaborations program is intended to encourage collaborations between researchers from an Alberta-based institution with researchers from institutions outside Alberta. Qualified investigators may seek funding for small research projects directly related to prion diseases and/or human neurodegenerative diseases and dementias where the etiology involves protein misfolding and the pathogenesis has prion-like characteristics. New Collaborations grants are intended to foster the development of new research partnerships by supporting short-term research projects aimed at addressing relevant fields of inquiry in the Prion Institute themes. Grants of up to $100,000 CAD for a maximum of two years are available. Deadline for proposals: Continuous.
     
  • Jeffrey Modell Foundation: Translational Research Program (Primary Immunodeficiency). The Jeffrey Modell Foundation encourages all investigators with the appropriate knowledge and research skill level to apply to this program. Applications submitted by investigators with vast expertise in Primary Immunodeficiency, as well as young investigators with robust scientific merit will all be considered. All international and U.S. applicants are eligible. The Foundation especially encourages investigators who are not currently receiving funding from the National Institutes of Health to apply. Upper amount: $250,000 USD over two years. Deadline for applications: February 15, 2018.
     
  • American Institute for Cancer Research (AICR): Research Grants. AICR's Investigator-Initiated Research Grant Program welcomes proposals for research addressing the effects of diet, nutrition, body composition, and physical activity on cancer risk and outcomes. Applications to this program must address either the Cancer Prevention or the Cancer Survivors Research Area and align with at least one of the Research Themes (Biological Mechanisms or Host Factors/Susceptibility); for research in the area of Cancer Survivors, applications are invited to address a third theme of Exposure-Outcome Relationships. Upper amount $150,000 USD over two years. Deadline for Letters of Intent: January 26, 2018. Full applications are due by May 11, 2018.
     
  • National Psoriasis Foundation: Sponsor deadline for all programs: January 19, 2018.
    • Pediatric Psoriasis Challenge Grants. In collaboration with the Pediatric Dermatology Research Alliance (PeDRA), the National Psoriasis Foundation (NPF) is seeking grant applications that encourage the advancement of innovative research into pediatric psoriasis. The 2018 Pediatric Psoriasis Challenge Grant will support projects that address any aspect of the disease, including the cause, diagnosis, or treatment of pediatric psoriasis and/or related comorbidities. Proposals from basic, translational, clinical, epidemiological, health services and other relevant research areas are all welcome. Upper amount $75,000 USD. 
    • Translational Research Grants: Translational Research Grants fund research initiatives that focus on the rapid translation of basic scientific discoveries into clinical applications with a clear benefit for patients with psoriatic disease. Applications related to all aspects of psoriatic disease are strongly encouraged, including basic science, translational research, technology, epidemiology, health services, and clinical research. Upper amount $200,000 USD.
    • Discovery Grants: Discovery Grants fund researchers while they explore preliminary ideas and conduct proof-of-concept experiments. The goal is to stimulate the development of new research programs in the field of psoriatic disease capable of competing for long-term funding from the National Institutes of Health or other agencies in the future. Upper amount: $75,000 USD.
       
  • Sarcoma Foundation of America: Research Grants. The Sarcoma Foundation of America has developed a program to provide grants to investigators interested in translational science sarcoma research. Funding is available to cover equipment and supplies in support of research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas.In accordance with the mission of the Foundation, research involving the development of novel agents against sarcoma, or research that could potentially lead to the development of novel agents against sarcoma, is eligible for this funding. Upper amount: $50,000 USD for one year. Deadline for applications: January 31, 2018.
     
  • Stiftelsen Promobilia - Promobelia Foundation: Grants for Research & Development Projects. The aim of the Foundation is to promote the development of technical aids so that disabled persons can benefit from a more active life. Their task is to support research and development of technical aids as well as to ensure that those products make it through production and reach those in need. The Foundation mainly gives support for development of tools for handicapped mobility but has also supported research on the comprehension of reading and writing difficulties. The Foundation has also supported research around diseases that can lead to severe motion problems. The Foundation gives grants in the range of SEK 100,000 - 500,000 (in USD about 10,000 - 100,000). Deadline for applications: March 22, 2018.
     
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01)
    • Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01)
    • Improving Implementation of Seek, Test, Treat and Retain Strategies among People Who Inject Drugs in Low to Middle Income Countries (R01)
    • Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01)
    • Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01) and (R21)
    • Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21) and (R01)
    • Self-Management for Health in Chronic Conditions (R01) and (R21)
    • Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01) and (R21)
    • Early-life Factors and Cancer Development Later in Life (R01) and (R03) and (R21)
    • Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01)
    • Advancing Basic Neurobiology Toward Translation Through Assay Development (R01)
    • Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21) and (R01) and (R03)
    • Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
    • Human Cell Biology of Alzheimer's Disease Genetic Variants (R01)
    • Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01)
    • Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21) and (R01)
    • Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21) and (R01)
    • Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
    • National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)
    • Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01)


December 19, 2017
 

  • CIFAR Azrieli Global Scholars Program 2018. The Canadian Institute for Advanced Research (CIFAR ) has announced a new opportunity for early career researchers. This initiative invites outstanding early-career researchers to work in collaborative research programs that address some of the most complex challenges facing the world today. The CIFAR Azrieli Global Scholars program provides funding and support to help early career researchers build their research network.  Scholars are appointed to a research program, becoming part of a global network of leading researchers pursuing answers to some of the most difficult challenges facing the world today. Research must align with the themes of an eligible CIFAR research program. The Research Services Office (RSO) will be offering editorial review of application drafts being submitted through UofT and received before the end of January. For this reason, RSO would appreciate a notice of interest via email to Joanna Baylon at joanna.baylon@utoronto.ca from potential applicants at this time so that we may schedule editorial support resources. Questions about this program should be directed to global.scholars@cifar.ca.
    Sponsor deadline: February 22, 2018.
     
  • Simons Foundation: SFARI Explorer Awards. Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder. Upper amount: $80,000 USD for one year. Deadline for applications: Continuous.
     
  • Friedreich's Ataxia Research Alliance (FARA): General Research Grants. FARA supports research through funding competitive grants, promoting collaboration among scientists, advocating for public-private partnerships that support drug discovery, drug development and clinical research and hosting open forums for leading scientists to share their insights, ideas and challenges to advancing treatments for FA.View Fara`s grant priorities. Upper amount: $300,000 USD for up to two years. Deadline for Letters of Intent: February 1, 2018; Full applications due: April 1, 2018.
     
  • Alzheimer's Drug Discovery Foundation (ADDF). Deadline for Letters of Intent for all programs: January 18, 2018 or April 13, 2018.
    • Biomarkers Development. This RFP seeks to support the development and validation of biomarkers that will enhance the design and performance of clinical trials for Alzheimer's disease, related dementias, and cognitive aging. Amount: $150,000-$300,000 USD/year for 1-2 years. 
    • Program to Accelerate Clinical Trials (PACT). This program will fund exploratory Phase 0 microdosing studies that assess preliminary target engagement and PK, Phase I safety testing, Phase 2 biomarker-based proof-of-concept clinical trials in patients, as well as IND-enabling studies to accelerate new drugs into trials. Through this PACT RFP, the ADDF is also interested in supporting biomarker-based trials to validate putative mechanisms of action for targeted pharmacological and non-pharmacological approaches to prevention. Amount: Up to $3,000,000 USD. 
    • Prevention Beyond the Pipeline. The ADDF seeks to support prevention drug discovery not covered by most research funders or their current RFPs. The average award varies. 
    • Drug Discovery (NEW). This Request for Proposals (RFP) focuses on supporting programs that aim to: 1. Advance novel lead molecules to the clinical candidate selection stage (defined as compounds suitable for IND-enabling studies); or 2. Build preclinical evidence in relevant animal models for repurposed/repositioned drugs or natural products. Amount: Up to $600,000 USD. 
       
  • NIH Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21)
    • Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21) and (R01)
    • Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01) and (R21)
    • Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21) and (R01)
    • Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01) and (R21)
    • Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01)
    • Epidemiology and Prevention in Alcohol Research (R01) and (R03) and (R21)
    • Research on Autism Spectrum (R03) and (R21) and (R01)
    • NIBIB Research Project Grant (R01 Clinical Trial Required); NIBIB Exploratory/Developmental Research Grant Program (R21) 
    • Tobacco Use and HIV in Low and Middle Income Countries (R21) and (R01)
    • Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21)
    • Multidisciplinary Studies of HIV/AIDS and Aging (R01) and (R21)
    • Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21) and (R01)
    • Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21)
    • Image-guided Drug Delivery (R01)
    • Understanding Immunopathogenesis of Tuberculosis in HIV-1 Infected and Exposed Children (R01)
    • Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01)
    • NICHD Research Project Grant (R01 Clinical Trial Required); NICHD Small Grant Program (R03); NICHD Exploratory/Developmental Research Grant (R21)
    • NIH Project Grant (R01); NIH Small Research Grant (R03): NIH Exploratory/Developmental Research Grant (R21)
    • Promoting Research in Basic Neuroscience (R01)
    • From Association to Function in the Alzheimers Disease Post-Genomics Era (R01)
    • Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01)
    • Pragmatic Trials of Managing Multimorbidity in Alzheimers Disease (R01 Clinical Trial Required)
    • Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01)
    • BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34) and (R01)
    • Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21) and (R01)
    • Synthetic Biology for Engineering Applications (R01) 
    • Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01)

       

December 8, 2017
 

  • Health System Impact (HSI) Fellowship Program. The HSI Fellowship program provides highly-qualified doctoral trainees and post-doctoral fellows studying health services and policy research (HSPR), or related fields (e.g., public health, informatics, economics, nursing), a unique opportunity to apply their research and analytic talents to critical challenges in health system and related organizations outside of the traditional scholarly setting (e.g., public, private for-profit, not-for-profit, and Indigenous health organizations), and to develop professional experience, new skills, and networks.  
    Information Webinar #1: Monday, December 11th, 2017, 11am-12pm EST
    Information Webinar #2: Monday, January 15th, 2018, 1pm - 2pm EST
    Webinar access details here.
     
  • SSHRC webinars on Insight Development Grant 2018 Competition. SSHRC will be holding webinars in English and French on the upcoming Insight Development Grants (IDG) 2018 competition. Each webinar will outline briefly what is new this year and focus on responding to questions. New this year, a detailed presentation is available in advance of the webinars by selecting these links (you do not need to have a Dropbox account in order to have access this presentation): English Presentation; French Presentation
    English Webinar: Tuesday, December 12, 2017, 1:00 p.m. to 2:30 p.m. (eastern)
    French Webinar: Monday, December 11, 2017, 10:30 a.m. to 12:00 p.m. (eastern)

    Webinar access details here
     
  • Now Launched: Genome Canada's Bioinformatics/Computation Biology Funding Competition. This competition is aimed at supporting research projects that address any aspects of bioinformatics and computational biology (B/CB) as it relates to genomics (and other high throughput 'omics technologies) across all of Genome Canada's sectors (i.e. human health, agriculture, aquaculture/fisheries, forestry, energy, mining and environment). It will support projects that build the tools and methodologies needed to analyze and integrate the vast amounts of data being gathered in the 'omics research community. Key Program Highlights: Project budget: $500-$1M per project total; Co-funding: 50% from Genome Canada + 50% from other eligible sources (1:1), Award duration: Up to three years. Draft registration deadline to Ontario Genomics: January 24, 2018; Final registration deadline: January 31, 2018; Draft full application deadline: February 7, 2018; Final application deadline: March 28, 2018. For more information please contact Kelly Hunter, Manager, Research & Business Development at khunter@Ontario.Genomics.ca. Examples of previously funded B/BC projects.
     
  • Mitacs Accelerate Fellowship: Long-term funding and training opportunity. Mitacs has launched a new opportunity for graduate students. The Mitacs Accelerate Fellowship provides long-term funding for a significant part of graduate degree programs:
    •    Master’s students can complete an 18-month project (minimum $30,000 stipend)
    •    PhD students can complete a three-year project (minimum $72,000 stipend)
    The Fellowship also offers national professional development training that helps interns gain in-demand career skills and ensure the success of their projects. Fellowships can form new Accelerate projects or be added to existing ones, and applications are accepted any time.
     
  • Government of Canada: Going Global Innovation (GGI). The GGI program is specifically designed to promote and enhance Canada's international innovation efforts. The program supports researchers who aim to commercialize technology by pursuing collaborative international research and development (R&D) opportunities through partnerships with key players in foreign markets. Eligible beneficiaries are Canadian innovators from small or medium size enterprises, universities and nongovernment research centres. GGI provides assistance by contributing up to 75% of eligible expenses, up to a maximum of $75,000 for any approved project. Eligible expenses may include international and local travel, accommodation, meals, meeting costs, legal fees to support formalized partnerships, and other costs related to international collaboration. Upper amount: $75,000 CAD. Deadline for applications: Continuous.
     
  • Cancer Research Institute: Focused Ultrasound and Cancer Immunotherapy Grant Program (FUSF-CFI). The aim of the grant program is to support projects that address critical unanswered research questions that will help move the field towards new device/drug combination therapies. This first request for proposals seeks preclinical projects to answer the following research question: How do different "modes" of focused ultrasound (i.e. ablative vs. non-ablative, thermal vs. mechanical) compare in terms of the immune response generated, and how does this immune response correlate with biological, acoustic and imaging metrics? The grant will be awarded to a single investigator who is leading a collaborative team that includes at least one FUS researcher and one cancer immunologist. Upper amount: $200,000 USD over 2 years. Deadline for Letters of Intent: January 15, 2018.
     
  • Society of Surgical Oncology: Clinical Investigator Award. The purpose of this award is to promote patient-oriented research conducted by surgical oncologists in clinical and translational science. The Foundation requests a proposal in which the applicant plays a central role in the conduct of a specific clinical research project. Of note, this award is not intended to serve as a career development award for new investigators seeking to initiate their research careers. Deadline for applications: January 7, 2018.
     

December 1, 2017
 

  • Women's College Hospital: Women's Xchange - $15K Challenge. Women’s Xchange invites you to apply for the $15K Challenge. The $15K Challenge awards up to $15,000 to individuals in organizations working to advance the health of women and girls in Ontario. Funding is available for one year to support research projects that address women’s health issues at the local level. From help on framing a research question to aid in communicating the results of your project to others, Women’s Xchange wants to support you. Women’s Xchange can help transform your ideas into research that will make an impact in the communities you serve.
    Deadline for Notice of Intent: January 8, 2018 at 4pm; Application deadline: February 8, 2018 at 4pm.
     
  • Westin Brain Institute: Transformational Research - Canada 2018. Larger, longer grants (up to $1.5m for up to 3 years) for transformational work that is novel, high-risk, high-reward and based on excellent preliminary data, including clinical studies not covered under the Early Phase Clinical Trials program below. Contact: rene.prashad@weston.ca or 416-965-5735. 
    *EXTENDED* - Deadline for Letters of Intent: February 15, 2018 at 2pm EST. 

     
  • CIHR: National Research Core – Canadian Microbiome Initiative 2: A Focus on Function and Translation. This new funding opportunity is part of the Canadian Microbiome Initiative 2 (CM12): A Focus on Function and Translation. The overall goal of this initiative is to enable the development of effective preventative and therapeutic interventions through a deeper understanding of the role of microbiome in human health. The Canadian Microbiome Initiative 2: A Focus on Function and Translation will support the next phase of microbiome research in Canada through two funding opportunities: Research Core (current competition) and Research Teams (future competition). Full details are available on ResearchNetDeadline for Letters of Intent: February 13, 2018.
     
  • CIHR: Sex- and Gender-Based Analysis (SGBA) Health Policy-Research Partnerships. The aim of this partnership is to fund Policy-Research Partnerships, which will help bridge the gaps between research knowledge and policy development and support the rigorous application of SGBA to ensure Health Canada's outward facing activities address the diverse needs of women, men, girls, boys and gender-diverse people to maximize positive health outcomes and improve health equity. Deadline for applications: January 23, 2018.
     
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)
    • Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
    • Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21)
    • Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)
    • Tobacco Regulatory Science (R01) and (R21)
    • Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21) and (R01)
    • mHealth Tools for Individuals with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R01) and (R21)
    • Pilot and Feasibility Therapeutic Clinical Trials in Diabetes, and Endocrine and Metabolic Diseases (R21- Clinical Trial Required)
    • NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional) 
    • Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01)
    • Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)

 

November 21, 2017
 

  • Ontario Centres of Excellence: Ontario-Jiangsu Industrial Research and Development Program. Launched in late 2016, OJIRDP fosters opportunities for international industry-academic R&D collaborations that have an impact in both Ontario and in the Jiangsu province of China. The current call for proposals will accept project applications focusing on the following technology sectors: 
    1.    Clean-Tech: Agrobiotech, Energy, Environment, Materials and Water Technologies
    2.    Information and Communication Technology:  Business Analytics, Security, Enterprise Applications, Software, Design and Development Tools, Broadband Access, Enterprise Networking, Home Networking, Mobile Applications, NGN & Convergence, Optical Networking, Telecom Applications, VoIP & IP Telephony, Wireless Applications and Wireless Infrastructure
    3.    Life Sciences: Agrobiotech, Bioinformatics, Biologicals, Diagnostics, Healthcare IT, Industrial, Medical Devices, Telemedicine and Therapeutics
    4.    Advanced and Intelligent Manufacturing
    UofT internal deadline: January 8, 2018; Sponsor deadline: January 15, 2018.
     
  • Mitacs Elevate: Winter 2018 (PostDoc fellowships, all disciplines). Mitacs Elevate is a postdoctoral fellowship with a customized research management training component. Elevate fellows progress through the program in a cohort, giving them cross-disciplinary networking and peer-learning opportunities they might not have otherwise in their careers. Over the two-year fellowship, Elevate fellows divide their time between their partner organization project and university-based research with their faculty supervisor. UofT internal deadline: January 17, 2018; Sponsor deadline: January 24, 2018.
     
  • Banting & Best Diabetes Centre (BBDC): Postdoctoral Fellowships 2018/2019. The BBDC will be awarding a number of postdoctoral fellowships to candidates at the post-PhD or post-MD degree stages.  The one-year fellowships normally commencing on July 1, 2018 (and no later than September 1, 2018) are for full-time research training in diabetes.  To be eligible, the candidate's proposed supervisor must be conducting diabetes research and must hold a faculty appointment with the University of Toronto at the level of Assistant, Associate, or Full Professor. Deadline for applications: February 13, 2018.
     
  • Parkinson Canada : 2018-2020 Research Program Funding Cycle. Important notice to applicants: The new Parkinson Canada online application submission system will help you manage the application process. Returning and new applicants must register and create a user name and password prior to beginning the online application process. Current funding opportunities: Pilot project grants (Includes Targeted Competition: Progressive Supranuclear Palsy (PSP) 1 Pilot Project Grant; New investigator awards; Fellowships; and Graduate students awards. Deadline for applications: February 1, 2018.
     
  • 2018 KRESCENT Post-Doctoral Fellowships and New Investigator Programs.  Applications to the Kidney Research Scientist Core Education and National Training Program (KRESCENT) program is open to applicants, from all disciplines relevant to kidney disease (i.e. biomedical, clinical, health services and population health disciplines). Deadline for applications: February 1, 2018.
     
  • Lupus Research Alliance: Target Identification in Lupus Grant (TIL Grants). All research funded under the TIL program is based on realizable goals and designed for "translational" research. This research is intended to be highly focused on lupus and, as such, should lead directly to knowledge that will facilitate drug discovery and/or testing of new treatments. These therapies may be used to treat systemic or organ-specific manifestations of lupus, although they may find applicability in the setting of other autoimmune or inflammatory illnesses. Upper amount: $200,000 USD per year for up to 3 years. Deadline for applications: February 9, 2018.
     
  • National MS Society. Applicants are required to submit pre-applications in advance of the due date.  NMSS will provide notification of approval, disapproval, or the need for changes within two business days of pre-application submission. 
    • Pilot Research Grants: The grants are awarded for 1 year for research conducted by scientists and clinicians that focus on unique or novel ideas with the potential to open significant new areas of research on multiple sclerosis. Upper amount $40,000 USD in direct costs. Deadline for pre-applications: January 8, 2018; Deadline for full applications: January 10, 2018.
    • Research Grants: The grants are awarded to multi-year research conducted by scientists and clinicians involving basic, clinical and rehabilitation research for a period of 1 to 5 years. Deadline for pre-applications: February 7, 2018; Deadline for full applications: February 14, 2018.
      ​​​
  • Leukemia Research Foundation: Hollis Brownstein - New Investigator Grants. The Foundation provides one year grants of $100,000 USD to selected New Investigator researchers, allows innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant breakthroughs. Deadline for Letters of Intent: February 1, 2018.
     
  • International Anesthesia Research Society: Frontiers in Anesthesia Research Award (FARA). Competitive applications of FARA must address one of the following areas of research: 1. Fundamental Neuroscience Unknowns (including anesthesia safety in children); 2. Immune, Inflammatory and Metabolic Consequences of Trauma, Surgery and Critical Care; 3. Best Use of Systems-Based Practice to Enhance Patient Safety & Quality. Principal applicant must be an IARS member. Upper amount: $750,000 USD payable over 3 years. Deadline for applications: January 30, 2018. 
     
  • Radiological Society of North America (RSNA): Research Seed Grant. The grant may be used in any area of research related to the radiologic sciences, from hypothesis-driven basic science and clinical investigations to topics such as drug, device, and therapy development; comparative effectiveness, evidence-based radiology, ethics and professionalism, quality improvement, clinical practice efficiency, and imaging informatics. Applicant must be an RSNA Member (at any level) at the time of application. Upper amount: $40,000 USD for one year. Deadline for applications: January 16, 2018.
     
  • National Psoriasis Foundation (NPF): Psoriatic Disease Research Fellowships. The program provides support to develop and enhance the opportunities for physicians training for research careers in academic dermatology, rheumatology, pediatric dermatology, and pediatric rheumatology. Priority consideration will be given to applications that advance psoriatic disease research. Fellowships may take place at any institution with an eligible fellowship program. Upper amount $50,000 USD. Deadline for applications: January 19, 2018.
     
  • Changes to U.S. Federal Grant Application Process. For a number of years, applicants have applied for U.S. federal grants by submitting a package of PDF forms through Grant.gov.  However, on Dec. 31, 2017, Grants.gov will officially retire the PDF package as a method to apply for U.S. federal grants and will be requiring that all applications for federal grants are completed and submitted through their on-line web tool called Workspace. Further details here.
     
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01)
    • NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33)
    • Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R01) and (R21)
    • The Health of Sexual and Gender Minority (SGM) Populations (R01) and (R03) and (R21)
    • Multidisciplinary Research in Vulvodynia (R01) and (R21)
    • End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01) and (R21)
    • Personalized Strategies to Manage Symptoms of Chronic Illness (R01) and (R21) 
    • Innovative Questions in Symptom Science and Genomics (R01) and (R21)
    • Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01) and (R21)
    • Mechanisms, Models, Measurement, and Management in Pain Research (R21)
    • Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21) 
    • Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required) and (R03 Clinical Trial Required) and (R21 Clinical Trial Required)
    • Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01) and (R03) and (R21)
    • Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01) and (R03) and (R21)
    • NIMH Exploratory/Developmental Research Grant (R21)
    • Human Subjects Mechanistic and Minimal Risk Studies (R01)
    • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clincial Trial Required) 
    • Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01)
    • Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01) and (R21) and (R03)
    • Selected Topics in Transfusion Medicine (R01) and (R21)
    • Bioengineering Research Grants (BRG) (R01) 
    • Pathogenesis of Age-Related HIV Neurodegeneration (R01)
    • Trophoblast Differentiation and Function (R21)
    • Zika Virus (ZIKV) Complications (R21) 
    • Fertility Status as a Marker for Overall Health (R21)
    • Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21)
    • International Research Collaboration on Drug Abuse and Addiction Research (R03) and (R21)
    • Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R21)
    • Exploratory/Developmental Clinical Research Grants in Obesity (R21)
    • Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)
    • NINDS Exploratory Neuroscience Research Grant (R21)
    • Addressing Health Disparities in NIDDK Diseases (R01)
    • Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21)
    • NCI Clinical and Translational Exploratory/Developmental Studies (R21)
    • Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21)
    • Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21)
    • Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01)
    • Mechanistic Basis of Diffuse White Matter Disease and Small Vessel Pathology in Vascular Contributions to Cognitive Impairment and Dementia (VCID) (R01)

 

November 10, 2017
 

  • University of Toronto - Connaught New Researcher Awards. The Connaught Committee is pleased to announce the New Researcher Award competition.  Up to $1,000,000 will be awarded in the 2017-18 academic year to help new tenure stream faculty members establish competitive research programs.  A majority of the available funds will be allocated to awards of up to $10,000; and the remaining funds will be allocated to top-up a limited number of these awards to a maximum of $35,000.  Top-up funding will be provided to the highest ranked proposals that also identify a specific need for the additional funding.  No matching required. Questions should be addressed to connaught.secretariat@utoronto.ca or 416-978-7118. Deadline for Applications: December 1, 2017.
     
  • Cancer Research Society: 2018 Operating Grant Competition. Partnerships: In addition to the regular grants that are available for all types of cancer, the Cancer Research Society is making some specific calls for operating grant proposals in particular areas of cancer research: Stomach/Esophagus Cancer (NEW); Von Hippel-Lindau Disease (NEW); Breast Cancer; Environmental Cancer; Ovarian Cancer; High-fatality, hard-to-treat, or metastatic (NEW); Pancreatic Cancer; Childhood Cancer; Bladder Cancer; and Kidney Cancer. Deadline for mandatory Letters of Intent: December 5, 2017; Deadline for full applications: February 15, 2018.
     
  • Weston Brain Institute:
    • Rapid Response: Canada 2018 (Parkinson's & Related Diseases). Seed funding (up to $200,000 per project for up to 18 months) to provide support for high-risk, high-reward projects that will accelerate the development of therapeutics for neurodegenerative diseases of aging. Contact: cristina.tang@weston.ca or 416-965-5356. Deadline for Letters of Intent: December 4, 2017 at 2pm EST.
    • Transformational Research: Canada 2018. Larger, longer grants (up to $1.5m for up to 3 years) for transformational work based on excellent preliminary data, including clinical studies not covered under the Early Phase Clinical Trials program below. Contact: rene.prashad@weston.ca or 416-965-5735Deadline for Letters of Intent: December 7, 2017 at 2pm EST. (may be extended)
    • Postdoctoral Scholars at Oxford: Provides funding (maximum £57,000 per year in salary + benefits, for 2 years) to exceptional Canadian postdoctoral researchers for international training at the University of Oxford and affiliation with Merton College. Projects must be translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging. Contact: rachel.reeve@weston.ca or 416-965-5656. Applications accepted on a rolling basis.
       
  • CIHR Updates on Fall 2017 Project Competition, evolution of peer review, and changes to Foundation Grant program. November 6, 2017.
     
  • Royal Bank of Canada Research Institute: Innovation Post-Doctoral & Graduate Fellowships. The RBC Research Institute Fellowship program will recognize emerging leaders who are establishing a record of research, scholarship and impact, and exhibit the potential to make significant contributions to the body of research in the field of entrepreneurship and innovation.  In addition to research excellence, preference will be given to those who have a demonstrated and/or future interest in entrepreneurship and company creation. Various outcomes and new knowledge of the RBC Fellows may be translated into knowledge with applications for policymakers, educators, service providers and entrepreneurs both at the University of Toronto and further afield. Deadline for Applications: November 30, 2017.
     
  • Muscular Dystrophy Association (MDA): Clinical Research Network Grants (NEW). MDA supports two clinical research networks -- one for Duchenne muscular dystrophy (DMD) and one for myotonic dystrophy (DM). Each consists of networks of multiple MDA Care Centers with special expertise in clinical research. The care centers, which were chosen through a competitive process, work together on projects selected by the network, such as clinical trials, natural history studies and other clinical research efforts. The investigators of the networks meet regularly by phone and in person to discuss ongoing and novel programs. Upper amount: $60,000 USD per centre per year for three years. Deadline for Letters of Intent: Continuous.
     
  • Citizens United for Research in Epilepsy (CURE). 
    • CURE Innovator Award. This award supports the exploration of a highly innovative, often risky new concept or untested theory that addresses an important problem relevant to epilepsy. The proposed research must reflect ideas substantially different from those being pursued by anyone in the epilepsy research field. Upper amount: $50,000 USD for one year. Deadline for Letters of Intent: January 8, 2018.
    • CURE Taking Flight Award. CURE seeks to promote the careers of young investigators to allow them to develop a research focus independent of their mentor(s). Researchers may propose basic or clinical studies, but this award mechanism is not intended to support clinical trials. Upper amount: $100,000 for one year. Deadline for Letters of Intent: January 8, 2018.
       
  • Pulmonary Fibrosis Foundation (PFF): The I.M. Rosenzweig Junior Investigator Awards and the Albert Rose Established Investigator Awards support projects that offer a high likelihood of improving the understanding of pulmonary fibrosis (PF) in the following areas: basic science, translational research, clinical medicine/research, and social science/quality of life. Deadline for Letters of Intent: November 30, 2017.
     
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01)
    • Fundamental Science Research on Mind and Body Approaches  (R21) and (R01)
    • Investigator-Initiated Clinical Trials Targeting Diseases within the Mission of NIDDK (R01-Clinical Trial Required) 
    • Role of Peripheral Proteostasis on Brain Aging and Alzheimer's Disease (R01)
    • Immunity in the Elderly (R01) 
    • Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) and (R01)
    • Mobile and Connected Health Interventions to Improve Care Continuum and Health Outcomes among Youth with HIV (R34) and (R01)
    • Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01)
    • Examination of Survivorship Care Planning Efficacy and Impact (R01) and (R21)
    • Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01) and (R21)
    • Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01) and (R21)
    • Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01) and (R21)
    • Diet and Physical Activity Assessment Methodology (R01) and (R21)
    • Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01)
    • Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01) and (R21)
    • Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development (R01)
    • Characterization of the Adolescent Reproductive Transition (R01) and (R03) and (R21)
    • Studies at Periviable Gestation (R01) and (R03) and (R21)
    • Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01) and (R03) and (R21)
    • Behavioral and Integrative Treatment Development Program (R01) and (R34) and (R03)
    • Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01) and (R21)
    • Prescription Drug Abuse (R01) and (R21)
    • The Application of Big Data Analytics to Drug Abuse Research (R01)
    • Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01) and (R21) and (R03)
    • Prevention Research in Mid-Life Adults (R01) and (R21)
    • Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01)
    • Functional Wellness in HIV: Maximizing the Treatment Cascade (R01) and (R21)
    • Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01)
    • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
    • NIH Research Project Grant (Parent R01 Clinical Trial Required)
    • Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01) and (R21)
    • Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01)
    • Dissemination and Implementation Research in Health (R01) and (R21)
    • Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01)
    • Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)
    • Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01) and (R21/R33) 
    • Outcome Measures for Use in Treatment Trials of Individuals with Intellectual and Developmental Disabilities (R01)
    • Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)
    • Natural History of Disorders Identifiable by Screening of Newborns (R01)
    • Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01)
    • Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01)
    • HIV/AIDS High Priority Drug Abuse Research (R01)



 

Back to Top